11/14/2024
6:47 PM | Celldex Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
11:18 AM | Celldex Therapeutics (Subject)
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
11/14/2024
5:12 AM | Celldex Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
11/13/2024
5:00 PM | Celldex Therapeutics (Subject)
Polar Capital Holdings Plc (Filed by)
| Form SC 13G/A | |
11/12/2024
8:55 AM | Celldex Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
11/08/2024
9:52 AM | Celldex Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/06/2024
3:06 PM | Celldex Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
|
06/14/2024
4:34 PM | Celldex Therapeutics (Subject)
Crowley Elizabeth (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
4:12 PM | Celldex Therapeutics (Subject)
Martin Samuel Bates (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
7:00 AM | Celldex Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2024
3:05 PM | Celldex Therapeutics (Issuer)
Young Diane C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:23 PM | Celldex Therapeutics (Subject)
Young Diane C. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024
4:51 PM | Celldex Therapeutics (Subject)
Jimenez Freddy A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024
4:14 PM | Celldex Therapeutics (Subject)
Wright Richard M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/30/2024
5:01 PM | Celldex Therapeutics (Subject)
Martin Samuel Bates (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/30/2024
5:05 PM | Cavanaugh Sarah (Reporting)
Celldex Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/30/2024
4:47 PM | Celldex Therapeutics (Subject)
Crowley Elizabeth (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/30/2024
2:20 PM | Celldex Therapeutics (Subject)
Heath-Chiozzi Margo (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/25/2024
7:00 AM | Celldex Therapeutics (Filer)
| Form DEF 14A | |
02/26/2024
7:18 AM | Celldex Therapeutics (Filer)
| Form 424B5 | |
02/26/2024
6:05 AM | Celldex Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/26/2024
6:01 AM | Celldex Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
11:52 AM | Celldex Therapeutics (Subject)
Kynam Capital Management, LP (Filed by)
| Form SC 13G | |
02/14/2024
10:48 AM | Celldex Therapeutics (Subject)
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
| Form SC 13G | |
02/14/2024
6:38 AM | Celldex Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
02/13/2024
8:41 AM | Celldex Therapeutics (Subject)
Polar Capital Holdings Plc (Filed by)
| Form SC 13G | |
02/09/2024
7:50 AM | Celldex Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
01/04/2024
3:05 PM | Celldex Therapeutics (Issuer)
Martin Samuel Bates (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
3:15 PM | Celldex Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G | |
